期刊文献+

2018 Chinese Pediatric Cardiology Society(CPCS) guideline for diagnosis and treatment of syncope in children and adolescents 被引量:58

2018 Chinese Pediatric Cardiology Society(CPCS) guideline for diagnosis and treatment of syncope in children and adolescents
原文传递
导出
摘要 Syncope belongs to the transient loss of consciousness(TLOC), characterized by a rapid onset, short duration, and spontaneous complete recovery. It is common in children and adolescents, accounting for 1% to 2% of emergency department visits.Recurrent syncope can seriously affect children's physical and mental health, learning ability and quality of life and sometimes cardiac syncope even poses a risk of sudden death. The present guideline for the diagnosis and treatment of syncope in children and adolescents was developed for guiding a better clinical management of pediatric syncope. Based on the globally recent development and the evidence-based data in China, 2018 Chinese Pediatric Cardiology Society(CPCS) guideline for diagnosis and treatment of syncope in children and adolescents was jointly prepared by the Pediatric Cardiology Society, Chinese Pediatric Society, Chinese Medical Association(CMA)/Committee on Pediatric Syncope, Pediatricians Branch, Chinese Medical Doctor Association(CMDA)/Committee on Pediatric Cardiology, Chinese College of Cardiovascular Physicians, Chinese Medical Doctor Association(CMDA)/Pediatric Cardiology Society, Beijing Pediatric Society, Beijing Medical Association(BMA). The present guideline includes the underlying diseases of syncope in children and adolescents, the diagnostic procedures, methodology and clinical significance of standing test and headup tilt test, the clinical diagnosis vasovagal syncope, postural orthostatic tachycardia syndrome, orthostatic hypotension and orthostatic hypertension, and the treatment of syncope as well as follow-up. Syncope belongs to the transient loss of consciousness(TLOC), characterized by a rapid onset, short duration, and spontaneous complete recovery. It is common in children and adolescents, accounting for 1% to 2% of emergency department visits.Recurrent syncope can seriously affect children's physical and mental health, learning ability and quality of life and sometimes cardiac syncope even poses a risk of sudden death. The present guideline for the diagnosis and treatment of syncope in children and adolescents was developed for guiding a better clinical management of pediatric syncope. Based on the globally recent development and the evidence-based data in China, 2018 Chinese Pediatric Cardiology Society(CPCS) guideline for diagnosis and treatment of syncope in children and adolescents was jointly prepared by the Pediatric Cardiology Society, Chinese Pediatric Society, Chinese Medical Association(CMA)/Committee on Pediatric Syncope, Pediatricians Branch, Chinese Medical Doctor Association(CMDA)/Committee on Pediatric Cardiology, Chinese College of Cardiovascular Physicians, Chinese Medical Doctor Association(CMDA)/Pediatric Cardiology Society, Beijing Pediatric Society, Beijing Medical Association(BMA). The present guideline includes the underlying diseases of syncope in children and adolescents, the diagnostic procedures, methodology and clinical significance of standing test and headup tilt test, the clinical diagnosis vasovagal syncope, postural orthostatic tachycardia syndrome, orthostatic hypotension and orthostatic hypertension, and the treatment of syncope as well as follow-up.
出处 《Science Bulletin》 SCIE EI CAS CSCD 2018年第23期1558-1564,共7页 科学通报(英文版)
  • 相关文献

参考文献5

二级参考文献28

  • 1韩阳,吕雪英,蒋伟莉,葛炜,陈天秩.西拉普利对血管迷走性晕厥多次发作患者的疗效观察[J].中华心血管病杂志,2004,32(8):729-732. 被引量:12
  • 2李雯,王成,李茗香,林萍,郑慧芬,谢振武.儿童血管迷走性晕厥的诱因与先兆分析[J].中国急救医学,2006,26(2):87-89. 被引量:14
  • 3Ronald JK. Syncope. In: Paul G, Arthur G, eds. Clinical Pediatric Arrthythmias. 2nd ed. Philadelphia: Saunders, 1999. 251-286.
  • 4Richard S, Daniel M. Indication, methodologe, and classification of results of tilt-table testing. Am J Cardiol, 1999,84(8A) :10Q-16Q.
  • 5Raviele A, Menozzi C, Brignole M, et al. Value of head-up tilt testing potentiated with subligual nitroglycerin to assess the origin of unexplained syncope. Am J Cardiol, 1995,76:267-272.
  • 6Raviele A, Casparini G, Di pede F, et al. Nitroglycerin infusion during upright tilt: a new test for the diagnosis of vasovagal syncope.Am Heart J, 1994,127:103-111.
  • 7Del Rosso A, Bartoletti A, Bartoli P, et al. Methodology of head-up tilt testing potentiated with subligual nitroglycerin in unexplained syncope. Am J Cardiol, 2000, 85:1007-1011.
  • 8Massin MM.Neurocardiogenic syncope in children:current concepts in diagnosis and management[J].Pediatr Drugs,2003,5(5):327-334.
  • 9Brignole M.Randomized clinical trial of neurally mediated syncope[J].J Cardiovasc Electrophsiol,2003,14(9 suppl):s64-69.
  • 10Kaufmann H,Saadia D,Voustianiouk A.Midodrine in neurally mediated syncope:a double-blind randomized crossover study[J].Ann Neurol,2002,52(3):342-345.

共引文献99

同被引文献224

引证文献58

二级引证文献99

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部